Gestational carriers, also known as surrogates, experience an elevated risk of severe maternal morbidity and adverse pregnancy outcomes compared to women who conceive naturally or through in vitro fertilisation (IVF), according to new research presented today at the ESHRE 40th Annual Meeting in Amsterdam [1].
Gestational carriers, also known as surrogates, experience an elevated risk of severe maternal morbidity and adverse pregnancy outcomes compared to women who conceive naturally or through in vitro fertilisation (IVF), according to new research presented today at the ESHRE 40th Annual Meeting in Amsterdam [1].
The population-based study analysed 937,938 singleton births in Ontario, Canada between 2012 and 2021, comparing outcomes among unassisted conceptions, IVF conceptions and gestational carriers.
The findings uncovered marked variations in outcomes across the different conception methods. Gestational carriers faced a severe maternal morbidity rate of 7.1%, notably higher than the rates observed in unassisted conceptions (2.4%) and IVF conceptions (4.6%).
Specifically, gestational carriers experienced elevated rates of postpartum haemorrhages and hypertensive disorders, both serious complications during pregnancy. Among gestational carriers, rates of postpartum haemorrhages were 13.9%, compared to 5.7% in unassisted conceptions and 10.5% in IVF conceptions. Similarly, hypertensive disorders, the most common medical problem encountered during pregnancy [2], affected gestational carriers at a rate of 13.9%, compared to 6.6% in unassisted conceptions and 11.6% in IVF conceptions.
Marina Ivanova, study author from Queen’s University in Kingston, Canada, comments, “There are several potential mechanisms that might explain the increased risk of severe maternal morbidity among gestational carriers. These include differences in baseline health or sociodemographic characteristics of those who choose to become gestational carriers, potential differences in prenatal care and monitoring, the physiological and psychological impact associated with carrying a pregnancy for another person, as well as the effects of the treatments used during the IVF process.”
“While some literature proposes that gestational carriers are carefully chosen based on favourable characteristics for a healthy pregnancy, our cohort did not consistently reflect this idea”, furthers Dr Maria Velez, study supervisor and senior author. “Gestational carriers were also less likely to be in the highest income bracket, and we know that lower socioeconomic status is associated with higher serious maternal morbidity rates. However, sociodemographic characteristics were accounted for in the analysis, and the results were similar, which suggest potential different mechanisms.”
A gestational carrier is defined as a woman who bears a genetically unrelated child for another person or couple [3]. Typically, IVF is used to fertilise the intended parent’s egg, and the resulting embryo is placed in the gestational carrier’s uterus.
Since the introduction of this method, the use of gestational carriers has been on the rise due to a number of factors, including increasing levels of infertility, a growing number of male same-sex couples seeking to have children, greater social acceptance of different family forms, advancements in medical technology and an increase in fertility clinics worldwide [4].
Despite the elevated risk of severe maternal morbidity and adverse pregnancy outcomes, the study did not find any significant difference in health outcomes for babies up to 28 days old between gestational carriers, unassisted conceptions, and IVF conceptions. Serious health problems were present in 6.5%, 6%, and 9.1% of neonates, respectively.
Marina Ivanova explains, “Even with the increased risk of severe maternal morbidity among gestational carriers, we were surprised to find no significant increase in severe neonatal morbidity compared to unassisted conceptions. While gestational carriers experience more complications, these do not necessarily lead to worse outcomes for the newborns, which is a positive finding.
In contrast, among women from the general population, severe maternal morbidity is associated with a higher risk of severe neonatal morbidity. This difference therefore warrants further investigation.”
Professor Dr Karen Sermon, Chair of ESHRE, explains, “These results highlight the impact of socioeconomic status on our reproductive health, and the need to surround candidate gestational carriers with the best standard of care. It is reassuring – and also intriguing – that children born to gestational carriers do not seem to be impacted by the higher pregnancy risks.”
The study abstract will be published today in Human Reproduction, one of the world’s leading reproductive medicine journals.
ENDS
Notes to editors:
A reference to the ESHRE Annual Meeting must be included in all coverage and/or articles associated with this study.
For more information or to arrange an expert interview, please contact the ESHRE Press Office at: press@eshre.eu
About the study author:
Marina Ivanova is a fourth-year medical student from Queen’s University, Kingston, Canada. Marina is passionate about advancing women’s health and aspires to leverage her medical career to advocate for reproductive justice in Canada and beyond.
Dr Maria Velez is an Associate Professor at Queen’s University, Department of Obstetrics and Gynaecology, Kingston, Canada.
About the European Society of Human Reproduction and Embryology (ESHRE)
The main aim of ESHRE is to promote interest in infertility care and to aim for a holistic understanding of reproductive biology and medicine.
ESHRE collaborates world-wide and advocates universal improvements in scientific research, encourages and evaluates new developments in the field, and fosters harmonisation in clinical practice. It also provides guidance to enhance effectiveness, safety and quality assurance in clinical and laboratory procedures, psychosocial care, and promotes ethical practice. ESHRE also fosters prevention of infertility and related educational programmes and promotes reproductive rights regardless of the individual’s background. ESHRE’s activities include teaching, training, professional accreditations, mentoring and career planning for junior professionals, as well as developing and maintaining data registries. It also facilitates and disseminates research in human reproduction and embryology to the general public, scientists, clinicians, allied personnel, and patient associations.
About Human Reproduction
Human Reproduction is a monthly journal of ESHRE and is one of the top three journals in the world in the field of reproductive biology, obstetrics and gynaecology. It is published by Oxford Journals, a division of Oxford University Press.
References:
- Ivanova, M., et al. (2024). Severe maternal and neonatal morbidity among gestational carriers: A population-based cohort study. Human Reproduction. Available at:
- Medscape. (2022). Hypertension and Pregnancy. Retrieved May 31, 2024, from
- Centers for Disease Control and Prevention. (2016). ART and Gestational Carriers. Retrieved May 31,2024, from
- Horsey, K. (2024) The future of surrogacy: A review of current global trends and national landscapes. Reproductive BioMedicine Online, 48(5), 103764,
